Los Angeles, U.S. | Xinhua | A U.S. investigational HIV vaccine regimen was safe but did not provide protection against HIV acquisition, according to a release of the U.S. National Institute of Health (NIH) on Wednesday. The trial, called HPX3002/HVTN 706 or “Mosaico,” began in 2019 and involved 3,900 volunteers ages …
Read More »
Kampala, Uganda | THE INDEPENDENT | More than one thousand volunteers have been enrolled to participate in another version of the HIV vaccine trial conducted by Ugandan scientists at the Medical Research Council-MRC. The new HIV vaccine known as “PrEPVacc” is being tested for its efficacy in the prevention of HIV, …
Read More »
Kampala, Uganda | THE INDEPENDENT | The Uganda Virus Research Institute will in May conduct a new HIV vaccine trial. Prof. Pontiano Kaleebu the Executive director of Uganda Virus Research Institute (UVRI), says that the participants will be given Pre-exposure Prophylaxis (PrEP) drugs to guard them against possible infection during …
Read More »
Kampala, Uganda | THE INDEPENDENT | The Director of the Uganda Virus Research Institute-UVRI Dr Pontiano Kaleebu has allayed fears that the HIV vaccine trials which were halted early this week in South Africa were not a waste of time. On Monday, the National Institute of Allergy and Infectious Diseases …
Read More »
Kampala, Uganda | THE INDEPENDENT | The National Institute of Health has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine. This is after an independent data and safety monitoring board (DSMB) found during a review that the regimen did not prevent HIV. The study, …
Read More »
The Independent Uganda: You get the Truth we Pay the Price